| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$229,248 |
|
|
|
Indirect Value
|
$200,574 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$429,822 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-05-30 |
4 |
AS |
$22.72 |
$67,926 |
I/I |
(2,925) |
290,687 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-05-29 |
4 |
AS |
$22.85 |
$67,163 |
I/I |
(2,925) |
293,612 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-04-26 |
4 |
AS |
$33.47 |
$130,533 |
I/I |
(3,900) |
304,337 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-04-25 |
4 |
AS |
$33.57 |
$131,049 |
I/I |
(3,900) |
308,237 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-04-11 |
4 |
AS |
$36.27 |
$141,453 |
I/I |
(3,900) |
312,137 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-04-10 |
4 |
AS |
$37.04 |
$144,456 |
I/I |
(3,900) |
316,037 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-29 |
4 |
AS |
$39.81 |
$155,637 |
I/I |
(3,900) |
319,937 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-28 |
4 |
AS |
$36.75 |
$145,909 |
I/I |
(3,900) |
323,837 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-15 |
4 |
AS |
$38.73 |
$151,047 |
I/I |
(3,900) |
327,737 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-14 |
4 |
AS |
$39.10 |
$156,906 |
I/I |
(3,900) |
331,637 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-28 |
4 |
AS |
$36.13 |
$140,907 |
I/I |
(3,900) |
335,537 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-27 |
4 |
AS |
$35.22 |
$140,984 |
I/I |
(3,900) |
339,437 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-15 |
4 |
D |
$40.45 |
$47,569 |
D/D |
(1,176) |
332,243 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-12 |
4 |
AS |
$39.01 |
$152,139 |
I/I |
(3,900) |
342,138 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-11 |
4 |
AS |
$38.52 |
$150,228 |
I/I |
(3,900) |
346,038 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-09 |
4 |
D |
$38.49 |
$782,271 |
D/D |
(20,324) |
334,618 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,683) |
375,611 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-01-24 |
4 |
AS |
$34.98 |
$136,783 |
I/I |
(3,900) |
296,452 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-01-23 |
4 |
AS |
$34.84 |
$136,650 |
I/I |
(3,900) |
300,352 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-01-10 |
4 |
AS |
$33.93 |
$133,581 |
I/I |
(3,900) |
4,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-01-09 |
4 |
AS |
$34.51 |
$135,889 |
I/I |
(3,900) |
7,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-28 |
4 |
AS |
$34.60 |
$135,340 |
I/I |
(3,900) |
11,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-27 |
4 |
AS |
$32.82 |
$128,893 |
I/I |
(3,900) |
15,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-13 |
4 |
AS |
$42.75 |
$166,725 |
I/I |
(3,900) |
19,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-12 |
4 |
AS |
$42.56 |
$165,984 |
I/I |
(3,900) |
23,578 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
